Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

2.

Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo.

Lee SJ, Krauthauser C, Maduskuie V, Fawcett PT, Olson JM, Rajasekaran SA.

BMC Cancer. 2011 Apr 18;11:144. doi: 10.1186/1471-2407-11-144.

3.
4.

Prolonged synovitis in pediatric Lyme arthritis cannot be predicted by clinical or laboratory parameters.

Brescia AC, Rose CD, Fawcett PT.

Clin Rheumatol. 2009 May;28(5):591-3. doi: 10.1007/s10067-009-1100-8. Epub 2009 Feb 5.

PMID:
19194735
5.
6.

Comparison of PCR and clinical laboratory tests for diagnosing H. pylori infection in pediatric patients.

Vinette KM, Gibney KM, Proujansky R, Fawcett PT.

BMC Microbiol. 2004 Jan 27;4:5.

7.

C6 test as an indicator of therapy outcome for patients with localized or disseminated lyme borreliosis.

Philipp MT, Marques AR, Fawcett PT, Dally LG, Martin DS.

J Clin Microbiol. 2003 Nov;41(11):4955-60.

8.

Growth of Helicobacter pylori in a long spiral form does not alter expression of immunodominant proteins.

Vinette KM, Gibney KM, Proujansky R, Fawcett PT.

BMC Microbiol. 2002 Sep 4;2:24. Epub 2002 Sep 4.

9.

In vitro assessment of antiborrelial activity of OspA vaccine sera.

Fawcett PT, Rose CD, Gibney KM.

Clin Diagn Lab Immunol. 2002 Jul;9(4):919-20.

10.

Arthritis following recombinant outer surface protein A vaccination for Lyme disease.

Rosé CD, Fawcett PT, Gibney KM.

J Rheumatol. 2001 Nov;28(11):2555-7.

PMID:
11708435
11.

Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans.

Philipp MT, Bowers LC, Fawcett PT, Jacobs MB, Liang FT, Marques AR, Mitchell PD, Purcell JE, Ratterree MS, Straubinger RK.

J Infect Dis. 2001 Oct 1;184(7):870-8. Epub 2001 Aug 30.

PMID:
11550127
12.

Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.

Fawcett PT, Rose CD, Budd SM, Gibney KM.

Clin Diagn Lab Immunol. 2001 Jan;8(1):79-84.

13.

Use of ELISA to measure antinuclear antibodies in children with juvenile rheumatoid arthritis.

Fawcett PT, Rose CD, Gibney KM, Emerich MJ, Athreya BH, Doughty RA.

J Rheumatol. 1999 Aug;26(8):1822-6.

PMID:
10451083
14.

Helicobacter pylori can be induced to assume the morphology of Helicobacter heilmannii.

Fawcett PT, Gibney KM, Vinette KM.

J Clin Microbiol. 1999 Apr;37(4):1045-8.

15.

Comparison of immunodot and western blot assays for diagnosing Lyme borreliosis.

Fawcett PT, Rosé CD, Gibney KM, Doughty RA.

Clin Diagn Lab Immunol. 1998 Jul;5(4):503-6.

16.

Correlation of seroreactivity with response to antibiotics in pediatric Lyme borreliosis.

Fawcett PT, Rosé CD, Gibney KM, Doughty RA.

Clin Diagn Lab Immunol. 1997 Jan;4(1):85-8.

17.

Residual serologic reactivity in children with resolved Lyme arthritis.

Rose CD, Fawcett PT, Gibney KM, Doughty RA.

J Rheumatol. 1996 Feb;23(2):367-9.

PMID:
8882048
18.

Pharmacokinetics of teratogenic antibodies administered to rats.

Fawcett LB, Beckman DA, Fawcett PT, Brent RL, LLoyd JB.

Teratology. 1995 Nov;52(5):260-6.

PMID:
8838249
19.

Comparative evaluation of adsorption with E. coli on ELISA tests for Lyme borreliosis.

Fawcett PT, Rose CD, Gibney KM.

J Rheumatol. 1995 Apr;22(4):684-8.

PMID:
7791164
20.

The overdiagnosis of Lyme disease in children residing in an endemic area.

Rose CD, Fawcett PT, Gibney KM, Doughty RA.

Clin Pediatr (Phila). 1994 Nov;33(11):663-8.

PMID:
7859425
21.
22.

Pediatric Lyme arthritis: clinical spectrum and outcome.

Rose CD, Fawcett PT, Eppes SC, Klein JD, Gibney K, Doughty RA.

J Pediatr Orthop. 1994 Mar-Apr;14(2):238-41.

PMID:
8188841
23.

Reinfection in paediatric Lyme borreliosis.

Rose CD, Fawcett PT, Klein JD, Eppes SC, Caputo GM, Doughty RA.

Ann Rheum Dis. 1993 Sep;52(9):695-6. No abstract available.

24.

Examination of anti-neutrophil cytoplasmic antibodies in childhood inflammatory bowel disease.

Proujansky R, Fawcett PT, Gibney KM, Treem WR, Hyams JS.

J Pediatr Gastroenterol Nutr. 1993 Aug;17(2):193-7.

PMID:
8229547
25.

Serial measurement of soluble interleukin 2 receptor levels: an early indicator of treatment response for Lyme disease.

Fawcett PT, Rose CD, Proujansky R, Gibney KM, Molloy DM, Doughty RA.

J Rheumatol. 1993 Jun;20(6):996-8.

PMID:
8350338
26.

Detection of antibodies to the recombinant P39 protein of Borrelia burgdorferi using enzyme immunoassay and immunoblotting.

Fawcett PT, Rose C, Gibney KM, Chase CA, Kiehl B, Doughty RA.

J Rheumatol. 1993 Apr;20(4):734-8.

PMID:
8496875
27.

Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens.

Fawcett PT, Gibney KM, Rose CD, Dubbs SB, Doughty RA.

J Rheumatol. 1992 Apr;19(4):582-7.

PMID:
1593581
28.

Use of western blot and enzyme-linked immunosorbent assays to assist in the diagnosis of Lyme disease.

Rose CD, Fawcett PT, Singsen BH, Dubbs SB, Doughty RA.

Pediatrics. 1991 Sep;88(3):465-70.

PMID:
1881724
29.

Adsorption with a soluble E. coli antigen fraction improves the specificity of ELISA tests for Lyme disease.

Fawcett PT, Gibney KM, Rose CD, Klein JD, Doughty RA.

J Rheumatol. 1991 May;18(5):705-8.

PMID:
1713972
30.
31.
32.

Glove powder and HIV ELISA tests.

Fawcett PT, Gibney KM, Doughty RA.

Lancet. 1989 May 13;1(8646):1082-3. No abstract available.

PMID:
2566035
33.

Suppression of malaria-induced autoimmunity by immunization with cryoglobulins.

Fawcett PT, Fawcett LB, Doughty RA, Coleman RM.

Cell Immunol. 1989 Jan;118(1):192-8.

PMID:
2642745
34.

Androgen suppression of circulating immune complexes and enhanced survival in murine malaria.

Coleman RM, Rencricca NJ, Fawcett PT, Veale MC, LoConte MA.

Proc Soc Exp Biol Med. 1982 Dec;171(3):294-7. No abstract available.

PMID:
6757933

Supplemental Content

Loading ...
Support Center